Sandu Pharmaceuticals Ltd — Important, 05-05-2026: Company Update

Sandu Pharmaceuticals held a board meeting where it approved the financial results for the quarter and year ended March 31, 2026. The company reported a net profit of 0.98 Cr for the quarter and 1.77 Cr for the full year. The Board also proposed a final dividend of Rs. 1 per equity share, subject to shareholder approval. M/s Shekhar Joshi & Co was appointed as the Cost Auditor, and M/S Akhil Pai & Co and M/S Uday & Uday Associates were engaged as Internal Auditors for different operations for the financial year 2026-27. The company confirmed it is not classified as a Large Corporate.